| Ambetter Health Texas Superior Marketplace Clinical | Bortezomib | 2026-02-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Bosentan | 2026-02-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Brexucabtagene Autoleucel | 2026-02-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Brolucizumab-dbll | 2026-02-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Budesonide | 2026-02-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Buprenorphine Injection | 2026-02-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Buprenorphine-Naloxone | 2026-02-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Cabotegravir, Cabotegravir/Rilpivirine | 2026-02-01 |
| Ambetter Health Texas Superior Marketplace Clinical | Cabozantinib | 2026-02-01 |
| Ambetter Health Texas Superior Medicaid Clinical | Depemokimab-ulaa | 2026-02-01 |